Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial.
Journal
Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664
Informations de publication
Date de publication:
10 Jun 2023
10 Jun 2023
Historique:
received:
27
01
2023
accepted:
30
05
2023
revised:
17
05
2023
medline:
12
6
2023
pubmed:
11
6
2023
entrez:
10
6
2023
Statut:
epublish
Résumé
The drivers of cognitive change following first-episode psychosis remain poorly understood. Evidence regarding the role of antipsychotic medication is primarily based on naturalistic studies or clinical trials without a placebo arm, making it difficult to disentangle illness from medication effects. A secondary analysis of a randomised, triple-blind, placebo-controlled trial, where antipsychotic-naive patients with first-episode psychotic disorder were allocated to receive risperidone/paliperidone or matched placebo plus intensive psychosocial therapy for 6 months was conducted. A healthy control group was also recruited. A cognitive battery was administered at baseline and 6 months. Intention-to-treat analysis involved 76 patients (antipsychotic medication group: 37; 18.6
Identifiants
pubmed: 37301832
doi: 10.1038/s41398-023-02501-7
pii: 10.1038/s41398-023-02501-7
pmc: PMC10257667
doi:
Substances chimiques
Risperidone
L6UH7ZF8HC
Antipsychotic Agents
0
Paliperidone Palmitate
R8P8USM8FR
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
199Subventions
Organisme : Department of Health | National Health and Medical Research Council (NHMRC)
ID : 1064704
Informations de copyright
© 2023. The Author(s).
Références
Schizophr Bull. 2014 Jul;40(4):744-55
pubmed: 23770934
Psychiatry Res. 2017 Jan;247:130-138
pubmed: 27888683
Schizophr Bull. 2013 Sep;39(5):993-8
pubmed: 23821768
Br J Psychiatry. 2008 Apr;192(4):248-57
pubmed: 18378982
JAMA Psychiatry. 2021 Jun 16;:
pubmed: 34132736
Psychiatry Res. 2022 Feb;308:114383
pubmed: 34999291
Am J Psychiatry. 2005 Oct;162(10):1888-95
pubmed: 16199835
Schizophr Res. 2010 Jun;119(1-3):1-10
pubmed: 20347270
Schizophr Bull. 2021 Aug 21;47(5):1243-1253
pubmed: 33761534
JAMA Psychiatry. 2018 Mar 1;75(3):270-279
pubmed: 29387877
JAMA Psychiatry. 2021 Dec 1;78(12):1305-1306
pubmed: 34524413
Neuropsychopharmacology. 2021 Jul;46(8):1494-1501
pubmed: 33637835
Am J Psychiatry. 2019 Oct 1;176(10):811-819
pubmed: 31256609
Schizophr Res. 2018 Mar;193:3-10
pubmed: 28634088
Arch Gen Psychiatry. 2007 Oct;64(10):1115-22
pubmed: 17909123
Acta Psychiatr Scand. 2009 Aug;120(2):102-11
pubmed: 19222405
Dialogues Clin Neurosci. 2019 Sep;21(3):227-237
pubmed: 31749647
BMC Geriatr. 2015 Mar 25;15:31
pubmed: 25879993
Clin Psychol Rev. 2017 Dec;58:59-75
pubmed: 29042139
J Exp Psychol Learn Mem Cogn. 1989 Jul;15(4):710-20
pubmed: 2526858
J Clin Psychopharmacol. 2013 Oct;33(5):675-81
pubmed: 23948784
Int J Neuropsychopharmacol. 1999 Jun;2(2):73-82
pubmed: 11281973
Psychol Med. 2018 Jan;48(1):132-141
pubmed: 28625185
Int J Epidemiol. 2005 Feb;34(1):215-20
pubmed: 15333621
Am J Psychiatry. 2009 Jun;166(6):675-82
pubmed: 19369319
JAMA Psychiatry. 2020 Apr 1;77(4):387-396
pubmed: 31825511
Neuropsychology. 2009 May;23(3):315-36
pubmed: 19413446
Int J Epidemiol. 2017 Apr 1;46(2):746-755
pubmed: 28025257
Neuropsychologia. 2002;40(3):302-16
pubmed: 11684163
Lancet. 2013 Sep 14;382(9896):951-62
pubmed: 23810019
Schizophr Res. 2014 Sep;158(1-3):156-62
pubmed: 25086658
Soc Psychiatry Psychiatr Epidemiol. 2020 Feb;55(2):151-164
pubmed: 31875238
BMJ. 2010 Mar 23;340:c869
pubmed: 20332511
JAMA Psychiatry. 2021 Sep 1;78(9):994-1004
pubmed: 34160595
Aust N Z J Psychiatry. 2011 Feb;45(2):93-108
pubmed: 21320033
Int J Neuropsychopharmacol. 2016 Apr 29;19(5):
pubmed: 26819282
Lancet Psychiatry. 2022 Mar;9(3):253-260
pubmed: 35114137
Psychol Med. 2018 Oct;48(13):2247-2256
pubmed: 29331153
Am J Psychiatry. 2001 Feb;158(2):176-84
pubmed: 11156796
Curr Drug Saf. 2019;14(3):173-181
pubmed: 30827259
Early Interv Psychiatry. 2019 Aug;13(4):953-960
pubmed: 30024100
Eur Psychiatry. 2012 May;27(4):275-80
pubmed: 21561741
BMC Med Res Methodol. 2013 Sep 28;13:119
pubmed: 24073634
Neurosci Biobehav Rev. 2021 Jul;126:265-275
pubmed: 33812977
Am J Psychiatry. 2007 Jul;164(7):1061-71
pubmed: 17606658
Am J Psychiatry. 2000 Jun;157(6):1019-20
pubmed: 10831489
J Psychopharmacol. 1999;13(3):238-44
pubmed: 10512078
J Int Neuropsychol Soc. 2012 Jul;18(4):717-27
pubmed: 22472219
Psychol Med. 2018 Jul;48(10):1592-1607
pubmed: 29173201
Psychopharmacology (Berl). 2013 Jun;227(4):615-25
pubmed: 23455591
Early Interv Psychiatry. 2023 Jun;17(6):597-607
pubmed: 36196478
Psychol Med. 2019 May;49(7):1138-1147
pubmed: 30058511
Psychol Med. 2021 Dec;51(16):2789-2797
pubmed: 32441236